Date published: 
9 June 2020
Intended audience: 
General public
Older female researcher at work in lab

Through the Medical Research Future Fund (MRFF), the Australian Government is investing in new clinical trial activity and providing greater access to cutting-edge ways to treat MND:

  • The MRFF-Adults with MND program, which aims to improve access to clinical trials and therapy outcomes for people living with MND by testing the effectiveness of repurposed drugs as potential treatment options.
  • The National Precision Medicine Program for MND Project, which aims to establish an Australian first Precision Medicine Program for MND. Precision medicine is the new frontier in personalised therapy using treatments targeted to the unique genetic and molecular makeup of patients with the promise of better clinical results.

For more information, see the media release